Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
Open Access
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 150, 30-39
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
- National Cancer Research Institute
- Manchester Biomedical Research Centre
- National Institute for Health and Care Research
- Cancer Australia
- Een Häerz fir kriibskrank Kanner (2U24CA180803-06)
This publication has 18 references indexed in Scilit:
- Radiation dose to heart base linked with poorer survival in lung cancer patientsEuropean Journal of Cancer, 2017
- Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclinesBlood, 2017
- Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma groupActa Oncologica, 2017
- ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1Radiotherapy and Oncology, 2016
- Anatomy and Physiology of the Pericardium2014
- Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative GroupActa Oncologica, 2012
- Radiation Oncology Safety Information System (ROSIS) – Profiles of participants and the first 1074 incident reportsRadiotherapy and Oncology, 2010
- Stereotactic body radiation therapy: The report of AAPM Task Group 101Medical Physics, 2010
- Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT):Journal of the ICRU, 2010
- Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registriesThe Lancet Oncology, 2005